# The Cigna Group (CI) · Edgar & Edgarette company card

> The Cigna Group (CI) grew revenue 11.2% in FY2025 to $274.9 billion, operating margin 3.3% against a 1.3% median for hospital & medical service plans, equity 26.4% of assets, and dividend per share up 5 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1739940 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CI) · [JSON](https://www.pops4.com/boards/company/CI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $274.9B |
| Revenue growth, 1 year | 11.2% |
| Revenue growth per year | 12.1% |
| Operating margin | 3.3% (prior year 3.8%) |
| Net margin | 2.3% |
| Operating cash flow | $9.6B |
| Capital spending | — |
| Free cash flow | — |
| Cash | $7.7B |
| Long-term debt | $30.9B |
| Total assets | $157.9B |
| Total equity | $41.7B |
| Equity ÷ assets | 26.4% |
| Return on equity | 15.1% |
| Dividend per share | $6.04 |
| Dividend years rising | 5 |

## Readings, computed from those figures

- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $274.9B (FY2025), total debt $30.9B. Experience: revenue up 11.2% on the year, up 12.1% a year over 4 years; operating margin 3.3%, down from 3.8%. Soundness: equity 26.4% of assets, return on equity 15.1%, payout 25.6% of profit, dividend per share up 5 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $270.7B and $333.6B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $246.9B to $362.7B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, hospital & medical service plans): operating margin 3.3% against a 1.3% median; growth 11.2% against 12.2%.

Range logged 2026-09-26, receipt 2d2961382494b000, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-10-09 ([filing](https://www.sec.gov/Archives/edgar/data/1739940/000114036126039271/0001140361-26-039271-index.htm))

## Recent filings

- 10-Q · filed 2026-11-05 · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000173994026000071/0001739940-26-000071-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000114036126042030/0001140361-26-042030-index.htm)
- 8-K · filed 2026-10-09 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000114036126039271/0001140361-26-039271-index.htm)
- 8-K · filed 2026-09-30 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000114036126038056/0001140361-26-038056-index.htm)
- 10-Q · filed 2026-07-30 · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000173994026000065/0001739940-26-000065-index.htm)
- 8-K · filed 2026-07-30 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1739940/000114036126030135/0001140361-26-030135-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001739940.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739940

## Cite

POPS4, Edgar & Edgarette: The Cigna Group (CI) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/CI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.